There were some brilliant gains this week, but unfortunately OPTI:Optibiotix
and PBX:Probiotix have gone to war and both suffered big losses which
absolutely hammered my portfolio. The deficit between cost and value widened
by £3,274 to £129,549 and deficit between injection amount and value went up
to £60,966. Total portfolio value dropped to £102,086 despite a £2k injection.
Biggest faller was PBX:Probiotix Health which lost all its recent gains and dropped 20% because it's almost certain the CEO will be sacked in a few weeks. I've certainly voted to sack him after he has shown utter contempt for PBX shareholders ever since he's been in position.
CWR:Ceres Power had a miserable week, dropping 18% and wiping out virtually all the potential profits from the recent rise. Given they have just become a FTSE 250 company, this is rather shocking, and lays waste any arguments that FTSE shares are more stable than AIM.
OPTI:Optibiotix went down 11%, partly due to the spat with PBX, especially given the CEO is in hospital and won't be able to work for a few more weeks, just as his company is under the biggest threat it has ever suffered.
AFC:AFC Energy has been an absolute disaster and dropped another 9% this week to go 58% down, when they were in profit just a few months ago.
ATYM:Atalaya Mining had a bad week after lackluster results, and dropped 6% to go 18% down.
Those were the big fallers, and unfortunately a couple are some of my biggest holdings, so although there were loads of big gains, they couldn't compete with these big losses.
FXPO:Ferrexpo seem to be a perfect trading share at the moment. They went up 18% this week, but I report on them at the beginning because they were 90% down and so not being reported on, but now are 89% down so I figure I should give them a mention. If my trading account wasn't a disaster I think I'd be trading these as they go up and down by 20%+ on a regular basis.
CORE:Solidcore Resources went up 5%. Still no sign of them re-listing in the UK, and they are still down by 83%, but if they do re-list and re-instate the dividend then they may still work out ok in the long run.
GAW:Games Workshop hovered around break-even for ages, but now seem to have forged ahead. They climbed 5% this week and are now 28% up, so I'm hoping that's enough of a buffer to keep them in the black for good.
IHP:Integrafin are doing what GAW used to do and hovering around break-even. They also went up 5% this week and are only 2% down now.
PSN:Persimmon are another 5% climber this week, and are now up by 15%. I don't think that's enough to guarantee staying in profit long term, but it's not bad.
CMCL:Caledonia Mining went up 6% and are already up by 23%. Given I sold EDV:Endeavour Mining to buy these, they have only just recovered the losses from the Burkina Faso nationalisation scare, whereas I've recouped my losses and gained some more by doing the switch. These are also way higher up my magic formula ranking than EDV so I don't regret the change.
SAE:Simec Atlantis Energy have been quite volatile recently. They went up 6% this week but are still 79% down.
AJB:AJ Bell has been one of my best investments. They went up 8% after really good results and are now 59% up since I bought them.
PAF:Pan African Resources has been absolutely amazing, and went up another 9% this week. My first holding is now up by 118%, with my other holding up 47% after buying more at a higher price.
ASHM:Ashmore Group had a brilliant week, climbing 10% presumably as favour is returning to emerging markets. They are still 23% down, but I'm hopeful they will recover that.
Share of the Week is SBTX:SkinBioTherapeutics which went up 16% after going up 17% last week. They are still well down, but seem to have some great momentum, and any announcement of a Croda deal should rocket them into profitability.
Here's the ISA and shares portfolio after week 12 of year 10.
| Weekly Change | |||
| Cash | £44.05 | +£3.70 | |
| Portfolio cost | £111,273.84 | +£85.66 | |
| Portfolio sell value (bid price-commission) | £40,908.75 | (-63.2%) | -£2,152.65 |
| Potential profits | £61.84 | -£360.16 | |
| Yr 10 Dividends | £20.65 | +£0 | |
| Yr 10 Interest | £0.37 | +£0.03 | |
| Yr 10 Profit from sales | £243.66 | +£93.91 | |
| Yr 10 proj avg monthly profit | £86.52 | (1.3%) | +£27.34 |
| Total Dividends | £12,243.14 | +£0 | |
| Total Interest | £7.17 | +£0.03 | |
| Total Profit from sales | £18,121.50 | +£93.91 | |
| Average monthly cash profit | £269.74 | (4.0%) | +£0.25 |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Compound performance | 37% | +1% |
There was some activity this week. I've been on a bit of an epic buying spree for JLP:Jubilee Metals, as if I interpret what's happening correctly, the institution that's selling everything has put a minimum sell price of 4.5p, because we've been sat at the same price for weeks despite there apparently being millions of sells. What's actually happening is there are millions of buys at around 4.524p, so I think the institution is selling at 4.5p to meet those buys. The market makers get the 0.024p for each transaction, but if they are getting through 4.5 million sells and buys a day, that's still £10,800 a day profit.
Based on that theory, I don't see the price dropping below 4.5p, which should mean it's reached the low point, and as soon as the institution finishes selling, assuming demand remains the same, then the price should rocket upwards. No doubt I'll be proved wrong next week, but I can't think of another reason for the current price action.
Meanwhile OPTI:Optibiotix is engaged in an absolute shit-show with PBX:Probiotix and I'm more nervous than I've ever been about the long term future of both companies. A couple of my OPTI purchases were below the current share price so I decided to sell them so I could buy some JLP. I sold 10,394 OPTI shares at 12.6211p and made £93.92 (7.7%) profit. Not a lot, but enough to buy 28,324 JLP shares at 4.518p costing £1,291.63.
Potential profits were almost entirely wiped out, losing £360 as the CWR:Ceres Power share price collapsed.
Huge £2k drop in value thanks to OPTI and PBX.
Might have known last week would have been a temporary blip.
Nothing if not consistent.
There was even more action in my SIPP this week, partly because my £2,000 transfer came through. I was planning to get N91:Ninety One and POLR:Polar Capital Holdings, but the JLP:Jubilee Metals story is too enticing so I bought 45,736 shares at 4.524p costing £2,081.05.
Might have known last week would have been a temporary blip.
Nothing if not consistent.
The SIPP looks like this after week 464 overall and week 48 of year 9.
| Weekly Change | ||||
| Cash | £131.79 | -£2.64 | ||
| Portfolio cost | £118,048.40 | +£2,152.79 | ||
| Portfolio sell value (bid price - commission) | £59,798.79 | (-49.3%) | -£1,170.22 | |
| Potential profits | £5,893.51 | +£840.41 | ||
| Yr 9 Dividends | £1,206.69 | +£80.95 | ||
| Yr 9 Interest | £6.45 | +£0.10 | ||
| Yr 9 Profit from sales | £5,606.15 | +£71.79 | ||
| Yr 9 proj avg monthly profit | £596.93 | (9.1%) | +£1.15 | |
| Total Dividends | £15,841.57 | +£80.95 | ||
| Total Interest | £12.38 | +£0.10 | ||
| Total Profit from sales | £16,442.05 | +£71.79 | ||
| Average monthly cash profit | £288.87 | (4.4%) | +£0.78 | |
| (Sold stocks profit + Dividends - Fees / Months) | ||||
| Compound performance | 39% | -1% |
There was even more action in my SIPP this week, partly because my £2,000 transfer came through. I was planning to get N91:Ninety One and POLR:Polar Capital Holdings, but the JLP:Jubilee Metals story is too enticing so I bought 45,736 shares at 4.524p costing £2,081.05.
I didn't stop there though. Despite CAML:Central Asia Metals being one of my favourite companies, I have already qualified for the dividend and there's not another one until next year, so I decided to sell a big chunk of them to move into JLP. I sold 2,060 shares at 182.0365p making £71.79 (1.9%) profit. Quite a puny profit, but it would be 14% if you include existing dividends, and there's another big dividend next week so it will be 20%+. I bought 82,361 JLP shares at 4.524p costing £3,737.96.
My JLP holding across all account is now 571,879 shares costing £38,008.84. I intend to hold my ISA shares long term, but I will sell 268,516 from other accounts for relatively small gains. I already have target prices for selling all of those, ranging from 9p to 12.5p. If everything goes to plan, I should make £11,533 profit on these shares and liberate £29,675 for magic formula shares, while still sitting on £40k profit in my ISA and maybe some dividends. All that would happen if the JLP share price gets to 20p, which I'm absolutely sure it will. I have however been know to be wrong in the past... JLP has been good to me over the years, with total realised profits of £14,259 making it one of my best investments. Troubling that I would have lost the lot if I'd not sold them.
Although portfolio value dropped by £1,170, potential profits went up by £870 thanks to big gains for many of my profitable shares. I also got a £80 dividend from IGG:IG Group.
Don't be fooled by the injection-let up-tick
That's more like it! Not as grim as the ISA but still the worst position in the last 12 months.
The trading account looks like this after week 430 overall and week 14 of year 9.
JLP:Jubilee Metals went up 1% and SBTX:SkinBioTherapeutix went up 16%, so the account gained £48 and SBTX is only down on commission. My target sell price is 23.5p and we're on 14.25p, so it may be a while yet, unless there's a Croda announcement.
Nice to see one of the accounts showing signs of revival
It's a healthy up-tick, but still way below the trend line and that's likely to swing downwards next week or the week after.
I was really hoping OPTI:Optibiotix and PBX:Probiotix would get around a table and sort out their differences, but the circular sent out by OPTI:Optibiotix suggests relations fell apart months ago, with OPTI convinced the CEO is trying to take the company private at a pittance. That could very well be the case, as the recent investor got in at rock-bottom prices and may have the capital to try and buy up the rest if the CEO keeps the price low. Having said that, there have been more communications since the investor came on board than in the whole period since IPO, and the share price would have been almost double what he came in on if it wasn't for the emergency meeting and threat of sacking the CEO, so it makes me question if that's the long-term plan, or was it just to get his mate 25% of the company dirt cheap before making some effort at increasing the share price. Whatever the motives, nothing he has done was for the benefit of existing shareholders, so despite the short term issues it will cause for the business, he really needs to go. I do worry that we'll be mired in legal shenanigans for months, and neither company can really afford that.
Don't be fooled by the injection-let up-tick
That's more like it! Not as grim as the ISA but still the worst position in the last 12 months.
The trading account looks like this after week 430 overall and week 14 of year 9.
| Weekly Change | |||
| Cash | £63.39 | +£0 | |
| Portfolio cost | £2,073.87 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,139.55 | (-45.1%) | +£48.04 |
| Potential profits | £0 | +£0 | |
| Year 9 Dividends | £0 | +£0 | |
| Year 9 Interest | £0 | +£0 | |
| Year 9 Profit | £0 | +£0 | |
| Yr 8 proj avg monthly profit | £0 | (+0%) | +£0 |
| Dividends | £85.46 | +£0 | |
| Interest | £0.03 | +£0 | |
| Profit from sales | -£602.54 | +£0 | |
| Average monthly cash profit | -£5.21 | (-3.0%) | +£0.01 |
| (Sold stocks profit + Dividends - Fees / Months) |
JLP:Jubilee Metals went up 1% and SBTX:SkinBioTherapeutix went up 16%, so the account gained £48 and SBTX is only down on commission. My target sell price is 23.5p and we're on 14.25p, so it may be a while yet, unless there's a Croda announcement.
Nice to see one of the accounts showing signs of revival
It's a healthy up-tick, but still way below the trend line and that's likely to swing downwards next week or the week after.
I was really hoping OPTI:Optibiotix and PBX:Probiotix would get around a table and sort out their differences, but the circular sent out by OPTI:Optibiotix suggests relations fell apart months ago, with OPTI convinced the CEO is trying to take the company private at a pittance. That could very well be the case, as the recent investor got in at rock-bottom prices and may have the capital to try and buy up the rest if the CEO keeps the price low. Having said that, there have been more communications since the investor came on board than in the whole period since IPO, and the share price would have been almost double what he came in on if it wasn't for the emergency meeting and threat of sacking the CEO, so it makes me question if that's the long-term plan, or was it just to get his mate 25% of the company dirt cheap before making some effort at increasing the share price. Whatever the motives, nothing he has done was for the benefit of existing shareholders, so despite the short term issues it will cause for the business, he really needs to go. I do worry that we'll be mired in legal shenanigans for months, and neither company can really afford that.
No comments:
Post a Comment